Healios: retinal pigment epithelium (RPE) clinical trials from 2017
According to Healios’ CEO Hardy TS KAGIMOTO, Helios plans to
According to Healios’ CEO Hardy TS KAGIMOTO, Helios plans to
The 800 m2 two story laboratory will be located in
The system with a photovoltaic power generation of 30 kW
„ReproNaive™“ is a medium component which keeps iPS cells in
The sales of Euglena-related products were 2,7 billion Yen in
Using Qiagen’s competence in extraction and amplification reagents for pre-processing
In the joint development of Sekisui Medical with the National
Using 13 varieties of rice straw and preprocessing technology, 47
RIKEN and Osaka University team visualize no stain non-invasive cell
The process is based on the feeding of .alpha.-levulinic acid